Clinical Trial Site Prioritization via Data-Driven Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional clinical trial monitoring techniques lack data-driven processes, leading to inefficient scheduling of monitoring visits and resource allocation, as they often rely on fixed intervals rather than site-specific needs and risk levels.
Innovation Solution
Implementing a data-driven monitoring system that uses information technology systems to assign site prioritization based on workload, risk indicators, and other factors, allowing for flexible scheduling and resource allocation tailored to individual clinical trial requirements and regulatory changes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If fixed interval monitoring is used, then monitoring coverage is ensured, but resource allocation efficiency deteriorates
Solution Approach 1:
The patent applies local quality by assigning different monitoring frequencies and resource allocation levels to different sites based on their specific risk profiles, workload characteristics, and performance metrics. High-risk sites receive more intensive monitoring while low-risk sites receive reduced monitoring, replacing the uniform fixed-interval approach with site-specific customized monitoring schedules.
Solution Approach 2:
The patent implements dynamics by making monitoring intervals and resource allocation flexible and adaptive rather than static. The system dynamically adjusts monitoring frequency and resource deployment based on real-time data from clinical trial operations, site performance indicators, and risk assessments, allowing the monitoring strategy to evolve as the trial progresses and conditions change.
2Manufacturing precision
If frequent site visits are scheduled, then data quality is improved, but time consumption increases
Solution Approach 1:
The patent applies parameter changes by using multiple varying parameters (risk scores, workload metrics, site performance indicators, data quality metrics) to determine monitoring frequency rather than a single fixed parameter. These parameters are continuously updated and weighted to optimize the balance between data quality assurance and time efficiency, allowing monitoring intensity to be precisely tuned to actual needs.
Solution Approach 2:
The patent implements self-service by enabling the monitoring system to automatically adjust visit schedules and resource allocation based on data from the clinical trial system itself. The system uses embedded sensors and data collection mechanisms to self-assess site performance and self-determine optimal monitoring intervals without requiring external manual intervention or fixed predetermined schedules.
3Ease of operation
If uniform monitoring approach is applied, then implementation simplicity is maintained, but adaptability to site-specific needs deteriorates
Solution Approach 1:
The patent applies universality by creating a single integrated monitoring platform that can universally serve all sites while simultaneously adapting to their specific needs. The system uses a common framework and data structure that works across all sites but incorporates flexible algorithms and parameters that automatically adjust to site-specific characteristics, risk profiles, and operational contexts.
Solution Approach 2:
The patent implements segmentation by dividing the monitoring approach into distinct segments or modules that can be independently configured for different sites. The system segments monitoring activities into risk assessment, performance tracking, and intervention planning components that can be selectively applied and customized for each site while maintaining overall system coherence and management simplicity.
Data Source
AI summary
Methods and apparatus for facilitating monitoring in a clinical trial. The method includes acts of receiving data from at least one information technology system configured to process clinical trial data, and assigning a site prioritization to each of a plurality of sites for at least one clinical trial associated with the at least one information technology system. Assigning a site prioritization is based, at least in part, on the received data. The method further includes an act of outputting an indication of the site prioritization.